Coronary microvascular dysfunction, central and overall obesity and metabolic and fibrotic biomarkers in patients with heart failure with preserved ejection fraction (data from PROMIS-HFpEF)

21 May 2023 (09:00 - 09:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Mikael Erhardsson

Karolinska Institute, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail

Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy

Doctor A. Nalbandian (New York, US)

Abstract Slides

Presentation thumbnail

Impact of temporary LV systolic dysfunction on long-term clinical outcome in patients with preserved ejection fraction after acute myocardial infarction

Doctor J. Kim (Seoul, KR)

Abstract Slides

Presentation thumbnail

Vascular stiffness, cardiac chamber stiffness and cardiovascular risk factors in women versus men with pre-HFpEF; a report from the PARABLE trial.

Doctor B. Wong (Dublin, IE)

Abstract Slides

Presentation thumbnail

Left-to-right ventricular volume ratio and outcome in heart failure with preserved ejection fraction

Doctor A. Aimo (Pisa, IT)

Abstract Slides

Presentation thumbnail

The prognostic value of hypoxemic burden measured by overnight oximetry in heart failure patients with preserved ejection fraction

Miss S. Mourmans (Maastricht, NL)

Abstract Slides

Access the full session

Session thumbnail

Heart failure with preserved ejection fraction (HFpEF) 1

The Event

Event poster

Heart Failure 2023

21 May 2023 09:00 CET

You may be interested in

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Webinar

Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources